Remote monitoring to manage nerve pain after chemotherapy
Part of Brain & nervous system, Cancer, Pain clinical trials.
This study tests whether remote check-ins (via phone/app/website) can help manage chemotherapy-related nerve pain in the hands and feet. It enrolls adults who developed nerve symptoms after certain cancer medicines and need ongoing monitoring.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 years or older.
- Have finished (or are on) certain chemotherapy or related treatments within the last 540 days, or ongoing maintenance/survival/palliative treatment for more than 90 days.
- Have developed chemotherapy-related nerve damage (CIPN) during treatment or within 3 months after the last dose, affecting the same cancer treatment period.
- Have at least one nerve symptom that is rated moderate or severe on a 6-item symptom questionnaire (within the past week or on screening day).
- Be able to speak and read enough English to talk by phone and use the English-only app/website.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a diet program delivered online to help reduce nerve damage symptoms like numbness and tingling caused by chemotherapy. It is for cancer survivors who completed treatment and still have these symptoms.
This study looks at how chemotherapy that can affect nerves (“neurotoxic” chemo) changes nerve function over time. It may help researchers better measure nerve side effects and improve care for people who need these cancer treatments.
This trial compares doing physical rehab at home via video calls versus in a clinic to help with nerve pain caused by chemotherapy in breast cancer patients. It tests if either approach can improve symptoms like numbness, tingling, or pain.
This study tests a new gel (VMD-3866) applied to the skin to treat moderate nerve pain, numbness, or tingling caused by previous chemotherapy. It aims to see if the gel can safely reduce pain for people whose symptoms have been stable for at least 8 weeks.
This study tests whether a small device that sends gentle electrical pulses to nerves in your leg can relieve pain caused by chemotherapy. If you have ongoing nerve pain in your legs from past chemo, this treatment might offer a new way to manage it.
This study tests whether a gentle, non-invasive brain stimulation (over the motor cortex) can help relieve pain caused by nerve damage from chemotherapy. It is for people who have completed cancer treatment at least 3 months ago and have ongoing painful neuropathy.
Hear when a new Chemotherapy-induced Peripheral Neuropathy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.